125Ser-Recombinant Human Interleukin-2 for Injection

广东卫伦生物制药有限公司🇨🇳 National Medical Products Administration

Approval Id: 7LeaezyRnQ3
Approval Number: 国药准字S20050012
Generic Name: 注射用重组人白介素-2(125Ser)
Generic Name En: 125Ser-Recombinant Human Interleukin-2 for Injection
Trade Name: 洛金
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 20万IU/瓶
Reg Date: 2020-02-19
Company Name: 广东卫伦生物制药有限公司
Production Company Name: 广东卫伦生物制药有限公司
Production Company Address: 广东省汕头市濠江区珠浦工业区内
Company Detail Path: /organization/yan-dong-wei-lun-sheng-wu-zhi-yao-you-xian-gong-si
Production Company Detail Path: /organization/yan-dong-wei-lun-sheng-wu-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Feb 19, 2020

Approval ID

7LeaezyRnQ3

Type

生物制品